NASDAQ:IBIO iBio Q1 2027 Earnings Results & Report $0.78 -0.02 (-1.89%) Closing price 04:00 PM EasternExtended Trading$0.78 0.00 (-0.26%) As of 06:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. iBio beat analyst expectations on both earnings and revenue in its Q1 2027 results, released November 10, 2026. The company reported EPS of -$0.05 versus the -$0.07 consensus estimate, while revenue of $1.08 million topped the $25 thousand estimate by $1.05 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2027Report DateNovember 10, 2026TimeBefore Market OpensConference Call4:00 PM ET iBio EPS ResultsActual EPS-$0.05Consensus EPS -$0.07Beat/MissBeat by +$0.02One Year Ago EPSN/AEPS Beat Rate2 of last 6 quartersiBio Revenue ResultsActual Revenue$1.08 millionExpected Revenue$25 thousandBeat/MissBeat by +$1.05 millionYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)SEC FilingEarnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) iBio Q1 2027 Earnings FAQ Did iBio beat earnings estimates for Q1 2027? iBio (NASDAQ:IBIO) reported earnings of -$0.05 per share for Q1 2027, beating the consensus estimate of -$0.07. The report was announced on Tuesday, November 10, 2026. What was iBio's revenue for Q1 2027? iBio reported revenue of $1.08 million for Q1 2027, against a consensus estimate of $25 thousand. iBio Earnings HeadlinesiBio Reports Q1 Fiscal Year 2027 Financial Results and Provides Corporate UpdateNovember 10 at 4:30 PM | globenewswire.comiBio (IBIO) Set to Announce Quarterly Earnings on WednesdayNovember 10 at 3:11 AM | americanbankingnews.comToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.November 10 at 1:00 AM | Behind the Markets (Ad)iBio to Participate in Upcoming Investor ConferencesNovember 2, 2026 | globenewswire.comAlpha buying: 3 beaten-down biotech stocks backed by a specialist investor - MSNOctober 29, 2026 | msn.comiBio Shareholders Approve Governance and Capital Structure ChangesOctober 19, 2026 | tipranks.comSee More iBio Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like iBio? Sign up for Earnings360's daily newsletter to receive timely earnings updates on iBio and other key companies, straight to your email. Email Address About iBioiBio (NASDAQ:IBIO) (NASDAQ: IBIO) is a biotechnology company focused on discovering and developing next-generation antibody therapeutics. The company uses artificial intelligence, machine learning and computational biology to identify and optimize antibody candidates for potential use in cancer and other serious diseases. iBio’s discovery capabilities are built around proprietary antibody-design and profiling technologies, including platforms intended to improve the speed and quality of therapeutic antibody development. The company has also pursued its own preclinical pipeline while evaluating potential partnerships and licensing opportunities for its drug candidates and discovery technologies. Historically, iBio was known for plant-based protein manufacturing and biologics development through its FastPharming technology, which was designed to produce proteins and antibodies using engineered plants. In more recent years, the company has shifted its emphasis toward artificial intelligence-enabled antibody discovery and therapeutic development. iBio is headquartered in the United States and serves the biopharmaceutical industry through its research, development and collaboration activities.View iBio ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Why Kinder Morgan's Chairman Just Bought $15 Million in StockA $4 Billion Jolt: NRG Energy Powers Data Center AmbitionsD-Wave Quantum Has Long-Term Potential, But Is Now the Time to Buy?Archer Aviation's FAA Certificate Is a Milestone, But It Isn't the Final OneRocket Lab's Record Backlog Could Fuel a Rebound, But Neutron Raises the StakesDraftKings Just Lost 20%—And Its Biggest Gamble Is Still AheadBarrick's Earnings Beat Could Be Overshadowed by an Even Bigger Opportunity Upcoming Earnings Franco-Nevada (11/11/2026)Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026)Cisco Systems (11/12/2026)Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
